Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
2,708,341
-
Share change
-
-190,256
-
Total reported value
-
$5,621,000
-
Price per share
-
$2.08
-
Number of holders
-
22
-
Value change
-
-$448,503
-
Number of buys
-
8
-
Number of sells
-
15
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2022
As of 30 Jun 2022,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,708,341 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BERKSHIRE ASSET MANAGEMENT LLC/PA, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.